Industry / Germany
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Proposed Drug Agency Scrapped
November 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
Plans to create a new drug approvals body in Germany have collapsed after the coalition parties in the government failed to agree on a framework for the agency. The new institution, provisionally called DAMA, would have replaced the current Federal Institute for Drugs and Medical Devices (BfArM) but there now seems little chance of the project being rehabilitated. Reform is still on the agenda but until the political infighting settles and a new roadmap becomes clear,